Study of Nasonex® for the Treatment of Nasal Polyps in Pediatric Subjects Between the Ages of 6 and Less Than 18 Years Old (Study P04292AM1)(COMPLETED) - Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00378378

Locations


United States, California
	Investigational Site 54
	Fresno, California, United States, 93720
	Investigational Site 56
	Downey, California, United States, 90241

United States, Missouri
	Investigational Site 7
	St. Louis, Missouri, United States, 63141

United States, New York
	Investigational Site 49
	Buffalo, New York, United States, 14209
	Investigational Site 6
	Valhalla, New York, United States, 10595

United States, Oklahoma
	Investigational Site 50
	Oklahoma City, Oklahoma, United States, 73120

United States, Texas
	Investigational Site 42
	Dallas, Texas, United States, 75246
	Investigational Site 42
	Dallas, Texas, United States, 75246
	Investigational Site 55
	San Antonio, Texas, United States, 78229

United States, Virginia
	Investigational Site 47
	Richmond, Virginia, United States, 23229

Colombia
	Investigational Site 9
	Bogota, Colombia
	Investigational Site 12
	Bogota, Colombia
	Investigational Site 11
	Bogota, Colombia
	Investigational Site 10
	Medellin, Colombia, 04

El Salvador
	Investigational Site 18
	San Salvador, El Salvador

Guatemala
	Investigational Site 15
	Guatemala, Guatemala, 01015
	Investigational Site 51
	Guatemala, Guatemala
	Investigational Site 13
	Guatemala, Guatemala, 01011

Honduras
	Investigational Site 16
	San Pedro Sula, Honduras
	Investigational Site 17
	San Pedro Sula, Honduras

Panama
	Investigational Site 19
	Panama, Panama

Peru
	Investigational Site 20
	Pueblo Libre, Peru, 21
	Investigational Site 21
	Miraflores, Peru, 18
	Investigational Site 22
	Cercado de Lima, Peru, 1
	Investigational Site 23
	La Victoria, Peru, Lima 13

Puerto Rico
	Investigational Site 24
	Rio Piedras, Puerto Rico, 00935

Singapore
	Investigational Site 26
	Singapore, Singapore, 119074

South Africa
	Investigational Site 28
	Benoni, South Africa, 1500

Sponsors and Collaborators

Schering-Plough

Investigators


Study Director:	Ariel Teper, MD	Schering-Plough